Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)
Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –
Ironwood Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Ironwood Pharmaceuticals's total assets was $285.13M at Jun 30, 2026. For fiscal 2025 it was $396.90M, up 13.1% from the year before. Over ten years it grew -4.3% a year on average. The highest annual figure on record is $1.13B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $396.90M | +13.1% |
| FY2024 | Dec 31, 2024 | $350.91M | -25.5% |
| FY2023 | Dec 31, 2023 | $471.07M | -57.2% |
| FY2022 | Dec 31, 2022 | $1.10B | -2.3% |
| FY2021 | Dec 31, 2021 | $1.13B | +101.5% |
| FY2020 | Dec 31, 2020 | $559.24M | +38.9% |
| FY2019 | Dec 31, 2019 | $402.75M | +21.3% |
| FY2018 | Dec 31, 2018 | $332.05M | -45.2% |
| FY2017 | Dec 31, 2017 | $605.67M | -14.7% |
| FY2016 | Dec 31, 2016 | $709.82M | +14.6% |
| FY2015 | Dec 31, 2015 | $619.12M | +88.0% |
| FY2014 | Dec 31, 2014 | $329.32M | +18.1% |
| FY2013 | Dec 31, 2013 | $278.96M | +21.3% |
| FY2012 | Dec 31, 2012 | $229.91M | +10.0% |
| FY2011 | Dec 31, 2011 | $208.98M | -30.7% |
| FY2010 | Dec 31, 2010 | $301.37M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $285.13M | -16.9% |
| Q1 FY2026 | Mar 31, 2026 | $434.57M | +32.8% |
| Q4 FY2025 | Dec 31, 2025 | $396.90M | +13.1% |
| Q3 FY2025 | Sep 30, 2025 | $396.06M | +1.7% |
| Q2 FY2025 | Jun 30, 2025 | $342.95M | -13.3% |
| Q1 FY2025 | Mar 31, 2025 | $327.21M | -25.4% |
| Q4 FY2024 | Dec 31, 2024 | $350.91M | -25.5% |
| Q3 FY2024 | Sep 30, 2024 | $389.52M | -25.7% |
| Q2 FY2024 | Jun 30, 2024 | $395.62M | -34.4% |
| Q1 FY2024 | Mar 31, 2024 | $438.82M | -62.0% |
| Q4 FY2023 | Dec 31, 2023 | $471.07M | -57.2% |
| Q3 FY2023 | Sep 30, 2023 | $524.06M | -49.6% |
| Q2 FY2023 | Jun 30, 2023 | $603.22M | -38.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.16B | +6.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.10B | -2.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.04B | -3.6% |
| Q2 FY2022 | Jun 30, 2022 | $975.69M | -3.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.08B | +80.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.13B | +101.5% |
| Q3 FY2021 | Sep 30, 2021 | $1.08B | +119.2% |
| Q2 FY2021 | Jun 30, 2021 | $1.01B | +127.1% |
| Q1 FY2021 | Mar 31, 2021 | $599.34M | +48.4% |
| Q4 FY2020 | Dec 31, 2020 | $559.24M | +38.9% |
| Q3 FY2020 | Sep 30, 2020 | $492.32M | +47.3% |
| Q2 FY2020 | Jun 30, 2020 | $443.54M | +40.5% |
| Q1 FY2020 | Mar 31, 2020 | $404.01M | +11.1% |
| Q4 FY2019 | Dec 31, 2019 | $402.75M | +21.3% |
| Q3 FY2019 | Sep 30, 2019 | $334.34M | -19.8% |
| Q2 FY2019 | Jun 30, 2019 | $315.72M | -48.9% |
| Q1 FY2019 | Mar 31, 2019 | $363.54M | -36.3% |
| Q4 FY2018 | Dec 31, 2018 | $332.05M | -45.2% |
| Q3 FY2018 | Sep 30, 2018 | $416.65M | -33.3% |
| Q2 FY2018 | Jun 30, 2018 | $618.22M | -12.3% |
| Q1 FY2018 | Mar 31, 2018 | $571.10M | -18.6% |
| Q4 FY2017 | Dec 31, 2017 | $605.67M | -14.7% |
| Q3 FY2017 | Sep 30, 2017 | $625.09M | -14.6% |
| Q2 FY2017 | Jun 30, 2017 | $705.08M | – |
| Q1 FY2017 | Mar 31, 2017 | $701.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $709.82M | – |
| Q3 FY2016 | Sep 30, 2016 | $731.98M | – |
See a number that looks wrong?